Drawing for XXL GENES

USPTO serial 78342258

XXL GENES

Reviewed by CopyMark Law Group

Reg. 3040072Status 710
Filing date
Status date
Registration date
Jan 10, 2006
Examiner
DAWE III, WILLIAM H
Law office
—

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with XXL GENES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Phil Makrogiannis

Phil Makrogiannis Life Technologies Corporation5791 Van Allen WayCarlsbad, CA 92008UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ Bacteria for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; bacteriological preparations for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; micro-organism cultures for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biological preparations for clinical, research and medical laboratory use, namely, proteins, DNA, RNA and modifications thereof; diagnostic preparations for clinical, research and medical laboratory use, namely, proteins, DNA, RNA and modifications thereof; and enzymes and enzyme preparations for use in the field of food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds ]SECTION 8 - CANCELLED—
005[ Medicines for human medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; bacteriological preparations for medical and veterinary purposes, for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis, as well as for use in gene therapy; biological preparations for medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; germicides for medical and institutional use, and domestic uses; vermicides for medical and institutional use, domestic use, and residential uses, fungicides for medical and institutional use, and domestic uses; biological preparations for medical diagnostic laboratory use, namely, proteins, DNA, RNA and modifications thereof; and diagnostic materials for clinical and medical laboratory purposes, namely, proteins, DNA, RNA and modifications thereof ]SECTION 8 - CANCELLED—
009Automatic machines for the synthesis of deoxyribonucleic acids; robotic machines for laboratory purposes, namely, pippetting robots, liquid handling robots, DNA synthesizer robots; computer terminals; computer programs for use as tools in the field of biotechnology and molecular biology; computer software to increase potency of enzymes and enzyme preparations, bacteria preparations, bacteriological preparations, micro-organism cultures, biological preparations, diagnostic preparations; computer operating programs; computer peripherals; computer keyboards; blank magnetic data carriers; blank optical disks; data processors; computer memories; blank floppy disks; hard drives for computers; printers for use with computers; computer interface boards; laptop computers; data processors, namely, readers and scanners; computer mouse; semiconductors; computer modems; computer monitors; computer hardware; and notebook computersSECTION 8 - CANCELLED—
042Computer services, namely, updating of computer software for others, consultation in the fields of biotechnology, designing computer software for others, maintenance of computer software for others, leasing of computer software, providing an online computer database in the fields of medicines, pharmaceuticals, and genomics, computer programming for others, leasing of computers, and recovery of computer data for others; chemical analysis for others; research for others in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; laboratory research services for others in the fields of of bacteriology and chemistry; consultation in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering and machine engineering; pharmaceutical consultation; measuring calibration for others; development and research of new products for others; technical consultation in the field of environmental protection; technical project planning and consulting services in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; and quality control for othersSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2016CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Mar 2, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 23, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 3, 2013NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 3, 2013C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 21, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 13, 2011PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Aug 19, 2011APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 2, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 11, 2011815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Jul 11, 2011E815TEAS SECTION 8 & 15 RECEIVED—
Jul 11, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 11, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 1, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 9, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 13, 2006ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 10, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 18, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 28, 2005NPUBNOTICE OF PUBLICATION—
Jul 7, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 1, 2005ALIEASSIGNED TO LIE—
Jun 27, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 18, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 10, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 10, 2005MAILPAPER RECEIVED—
May 16, 2005GNCFCONTINUATION OF FINAL REFUSAL E-MAILED—
May 16, 2005CNCFACTION CONTINUING A FINAL - COMPLETED—
May 5, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
May 5, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 16, 2005ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 4, 2005CWBPWITHDRAWN BEFORE PUBLICATION—
Feb 5, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 4, 2005ALIEASSIGNED TO LIE—
Jan 13, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 11, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 13, 2004MAILPAPER RECEIVED—
Dec 10, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2004MAILPAPER RECEIVED—
Dec 5, 2004GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 5, 2004CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 4, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 15, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 15, 2004MAILPAPER RECEIVED—
Aug 5, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2004DOCKASSIGNED TO EXAMINER—
Jan 7, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance